| Year |
Citation |
Score |
| 2023 |
Radyk MD, Nelson BS, Halbrook CJ, Wood A, Lavoie B, Salvatore L, Corfas G, Colacino JA, Shah YM, Crawford HC, Lyssiotis CA. Glucose-6-phosphate dehydrogenase deficiency accelerates pancreatic acinar-to-ductal metaplasia. Biorxiv : the Preprint Server For Biology. PMID 37986898 DOI: 10.1101/2023.11.06.565895 |
0.788 |
|
| 2022 |
Halbrook CJ, Thurston G, Boyer S, Anaraki C, Jiménez JA, McCarthy A, Steele NG, Kerk SA, Hong HS, Lin L, Law FV, Felton C, Scipioni L, Sajjakulnukit P, Andren A, ... ... Nelson BS, et al. Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells. Nature Cancer. 3: 1386-1403. PMID 36411320 DOI: 10.1038/s43018-022-00463-1 |
0.788 |
|
| 2022 |
Kerk S, Lin L, Myers AL, Sutton DJ, Andren A, Sajjakulnukit P, Zhang L, Zhang Y, Jiménez JA, Nelson BS, Chen B, Robinson A, Thurston G, Kemp SB, Steele NG, et al. Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context. Elife. 11. PMID 35815941 DOI: 10.7554/eLife.73245 |
0.786 |
|
| 2021 |
Kremer DM, Nelson BS, Lin L, Yarosz EL, Halbrook CJ, Kerk SA, Sajjakulnukit P, Myers A, Thurston G, Hou SW, Carpenter ES, Andren AC, Nwosu ZC, Cusmano N, Wisner S, et al. GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis. Nature Communications. 12: 4860. PMID 34381026 DOI: 10.1038/s41467-021-24859-2 |
0.744 |
|
| 2020 |
Zhou W, Yao Y, Scott AJ, Wilder-Romans K, Dresser JJ, Werner CK, Sun H, Pratt D, Sajjakulnukit P, Zhao SG, Davis M, Nelson BS, Halbrook CJ, Zhang L, Gatto F, et al. Purine metabolism regulates DNA repair and therapy resistance in glioblastoma. Nature Communications. 11: 3811. PMID 32732914 DOI: 10.1038/S41467-020-17512-X |
0.702 |
|
| 2020 |
Nelson BS, Lin L, Kremer DM, Sousa CM, Cotta-Ramusino C, Myers A, Ramos J, Gao T, Kovalenko I, Wilder-Romans K, Dresser J, Davis M, Lee HJ, Nwosu ZC, Campit S, et al. Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy. Cancer & Metabolism. 8: 1. PMID 31908776 DOI: 10.1186/S40170-019-0202-2 |
0.659 |
|
| 2019 |
Halbrook CJ, Pontious C, Kovalenko I, Lapienyte L, Dreyer S, Lee HJ, Thurston G, Zhang Y, Lazarus J, Sajjakulnukit P, Hong HS, Kremer DM, Nelson BS, Kemp S, Zhang L, et al. Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer. Cell Metabolism. PMID 30827862 DOI: 10.1016/J.Cmet.2019.02.001 |
0.726 |
|
| 2019 |
Halbrook CJ, Nelson BS, Lysstiotis CA. Metabolism Drives Carcinogenesis and Maintenance of Pancreatic Tumors. Cancer Discovery. 9: 326-328. PMID 30824487 DOI: 10.1158/2159-8290.CD-19-0034 |
0.739 |
|
| 2019 |
Halbrook CJ, Pontious C, Kovalenko I, Lapienyte L, Dreyer S, Zhang Y, Nelson B, Hong H, Chang D, Morton JP, Magliano MPd, Lyssiotis CA. Abstract 4549: Macrophage-epithelial metabolic crosstalk impairs chemotherapy in pancreatic cancer Cancer Research. 79: 4549-4549. DOI: 10.1158/1538-7445.Sabcs18-4549 |
0.602 |
|
| 2018 |
Nelson BS, Kremer DM, Lyssiotis CA. New tricks for an old drug. Nature Chemical Biology. 14: 990-991. PMID 30297874 DOI: 10.1038/s41589-018-0137-x |
0.672 |
|
| 2016 |
Meyer KA, Neeley CK, Baker NA, Washabaugh AR, Flesher CG, Nelson BS, Frankel TL, Lumeng CN, Lyssiotis CA, Wynn ML, Rhim AD, O'Rourke RW. Adipocytes promote pancreatic cancer cell proliferation via glutamine transfer. Biochemistry and Biophysics Reports. 7: 144-149. PMID 27617308 DOI: 10.1016/j.bbrep.2016.06.004 |
0.654 |
|
| 2016 |
Meyer KA, Neeley CK, Baker NA, Washabaugh AR, Flesher CG, Nelson BS, Frankel TL, Lumeng CN, Lyssiotis CA, Wynn ML, Rhim AD, O'Rourke RW. Adipocytes promote pancreatic cancer cell proliferation via glutamine transfer Biochemistry and Biophysics Reports. 7: 144-149. DOI: 10.1016/j.bbrep.2016.06.004 |
0.654 |
|
| Show low-probability matches. |